DocDollars

Astrazeneca Ab

Sweden · Reporting entity ID 100000000160

Total reported 2019–2025
$28.0M
#255 of 2,960 reporting companies — 0% of all reported industry payments
$6.78M in general payments across 1,246 records, plus $21.3M in research funding across 710 records.

How it breaks down

General payments $6,784,321
Research funding $21,250,044

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Astrazeneca Ab reported $28.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #255 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 1,246 general payment records and 710 research records were filed.

Common questions about Astrazeneca Ab

How much has Astrazeneca Ab paid US doctors?

Astrazeneca Ab reported $28,034,365 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,784,321 in general payments, $21,250,044 in research funding.

How does Astrazeneca Ab rank among drug and device companies?

It ranks #255 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Astrazeneca Ab mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.